Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06743659 · ClinicalTrials.gov registry record · NA
Computerized Decision Support for Identification and Management of Familial Hypercholesterolemia
A NA study of Familial Hypercholesterolaemia, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 450
- Enrollment target
- 1
- Study location
NCT06743659: Recruiting NA study of Familial Hypercholesterolaemia, sponsored by Brigham and Women's Hospital.
NCT06743659 is a NA study of Familial Hypercholesterolaemia that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 450 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06743659, a NA study of Familial Hypercholesterolaemia, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 450 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if a computer alert can aid clinicians in identifying patients with a genetic type of high cholesterol, called Familial Hypercholesterolemia. The main question it aims to answer is whether the computer alert increases recognition of this high cholesterol disorder.
Primary Outcome
We will review the medical history, visit diagnosis, and problem list sections of the Electronic Health Record (EPIC) to make this determination of diagnosis of Familial Hypercholesterolemia.
Conditions Studied
Interventions
- DEVICE Alert-based computerized decision support
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What NCT06743659 shows while recruiting
NCT06743659 is an interventional study that assigns participants to a tested intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower).
The record links to 1 condition, with Familial Hypercholesterolaemia appearing as the primary indexed condition, and to 1 intervention - of which Alert-based computerized decision support is the first listed.
NCT06743659 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06743659 about?
NCT06743659 is a clinical study titled "Computerized Decision Support for Identification and Management of Familial Hypercholesterolemia". The goal of this clinical trial is to learn if a computer alert can aid clinicians in identifying patients with a genetic type of high cholesterol, called Familial Hypercholesterolemia. The main question it aims to answer is whether the computer alert increases recognition of this high cholesterol d...
What is the current status of trial NCT06743659?
This trial is currently recruiting. It is a NA study. The enrollment target is 450 participants. The study started on 2025-04-01. Estimated completion is 2027-12-31.
What conditions does trial NCT06743659 study?
This clinical trial studies the following conditions: Familial Hypercholesterolaemia.
What interventions are being tested in trial NCT06743659?
The interventions under investigation include: Alert-based computerized decision support (DEVICE).
Who is sponsoring clinical trial NCT06743659?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06743659 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Familial Hypercholesterolaemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06743659's enrollment target sits among peer trials
450 225th of 2000 higher than 1,768 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
- NCT03047161 · 450 participants
Electrophysiology of Fetal Arrhythmia
- NCT03269630 · 450 participants
New Orleans Pulmonary Hypertension Biobank
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI